Literature DB >> 10424599

Signal transduction by tumor necrosis factor: the Parker B. Francis Lectureship.

D V Goeddel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10424599     DOI： 10.1378/chest.116.suppl_1.69s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  11 in total

Review 1.  The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters.

Authors:  J Moscat; M T Diaz-Meco
Journal:  EMBO Rep       Date:  2000-11       Impact factor: 8.807

Review 2.  Tumour necrosis factor in mouse models of chronic intestinal inflammation.

Authors:  Christoph Mueller
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

Review 3.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

Review 4.  Humoral sleep regulation; interleukin-1 and tumor necrosis factor.

Authors:  Kathryn A Jewett; James M Krueger
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

5.  TRANSLATION OF BRAIN ACTIVITY INTO SLEEP.

Authors:  James M Krueger
Journal:  Hirosaki Igaku       Date:  2012

Review 6.  Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.

Authors:  Bharat B Aggarwal; Subash C Gupta; Ji Hye Kim
Journal:  Blood       Date:  2011-11-03       Impact factor: 22.113

7.  Identification of phylogenetic footprints in primate tumor necrosis factor-alpha promoters.

Authors:  J Y Leung; F E McKenzie; A M Uglialoro; P O Flores-Villanueva; B C Sorkin; E J Yunis; D L Hartl; A E Goldfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

8.  Myosin ii light chain phosphorylation regulates membrane localization and apoptotic signaling of tumor necrosis factor receptor-1.

Authors:  Y Jin; S J Atkinson; J A Marrs; P J Gallagher
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

9.  MADD, a splice variant of IG20, is indispensable for MAPK activation and protection against apoptosis upon tumor necrosis factor-alpha treatment.

Authors:  Bapi Raju V V S N Kurada; Liang Cheng Li; Nirupama Mulherkar; Mahesh Subramanian; Kanteti V Prasad; Bellur S Prabhakar
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

Review 10.  Tumor necrosis factor alpha in sleep regulation.

Authors:  Matthew D Rockstrom; Liangyu Chen; Ping Taishi; Joseph T Nguyen; Cody M Gibbons; Sigrid C Veasey; James M Krueger
Journal:  Sleep Med Rev       Date:  2017-11-17       Impact factor: 11.609
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.